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Summary
The aim of this review article is to present new sophisticated techniques in radiotherapy, which occurred due to the 
advancement of technology over the past few decades. The paper will provide insight into their advantages and disadvan-
tages, the importance of diagnostic imaging modality, precise contouring, treatment planning and control of patients’ posi-
tion during radiation treatment. The transition from two-dimensional to three-dimensional radiotherapy has allowed con-
touring of target volume and organs at risk and accurate information on radiation dosage delivered. With a further desire 
for more precision and protection of healthy tissues, techniques such as intensity modulated radiotherapy (IMRT) and volu-
metric modulated arc therapy (VMAT) have been developed with the ability to modulate beam intensity. Quality imaging 
diagnostics is an infallible part of the modern radiotherapy. Image-guided radiotherapy (IGRT) and adaptive radiotherapy 
enable the delivery of high precision radiation to the target volume and spares organs at risk by correcting interfractional 
and intrafractional variations. Respiratory gating and tracking technique are useful for tumours that change their position 
during respiratory cycle. Stereotactic ablative radiotherapy (SABR) is a technique that uses highly conformal high-dose 
hypofractionated radiation to treat small tumours. In some indication such as the treatment of early stage non-small lung 
cancer, it competes with radical surgery. SABR is also an important therapeutic modality in the management of oligometa-
static disease. This paper will briefly discuss proton therapy and its unique physical properties.
KEY WORDS:  intensity-modulated radiation therapy, image-guided radiotherapy, volumetric modulated arc therapy, adaptive 
radiotherapy, stereotactic ablative radiotherapy, proton therapy
MODERNE METODE RADIOTERAPIJE
Sažetak
Cilj ovog preglednog rada je prikazati nove sofisticirane metode radioterapije koje su se razvile zahvaljujući napretku 
tehnologije unazad par desetljeća. Osvrnut ćemo se na njihove prednosti i nedostatke, važnost slikovne obrade, preciznog 
konturiranja, planiranja radioterapije i kontrole pozicije pacijenta tijekom radioterapije. Prijelaz s konvencionalne dvodi-
menzionalne na konformalnu trodimenzionalnu radioterapiju je omogućio konturiranje ciljnog volumena i organa od rizika 
te praćenje isporučene radioterapijske doze. Daljnjom željom za još većom preciznošću i poštedom zdravih tkiva razvile su 
se još naprednije tehnike poput radioterapije snopovima promjenjivog intenziteta (IMRT) i volumetrijski modulirane lučne 
terapije (VMAT) koje imaju mogućnost moduliranja intenziteta snopa. Kvalitetna slikovna dijagnostika je neizostavan dio 
moderne radioterapije. Radioterapija vođena slikom (IGRT) i adaptivna radioterapija omogućuju isporuku visokopreciznog 
zračenja na ciljni volumen i poštedu organa od rizika korigiranjem interfrakcionarnih i intrafrakcionarnih varijacija. Gating 
tehnika i tracking tehnika su korisne kod pomičnih tumora tijekom ciklusa disanja. Stereotaktička ablativna radioterapija 
(SABR) je tehnika koja koristi visokokonformalno, visokodozno hipofrakcionirano zračenje u liječenju malih tumora. U ne-
kim indikacijama, kao npr. liječenje karcinoma nemalih stanica pluća ranog stadija, ova metoda može zamijeniti kirurški 
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zahvat. Važan je terapijski modalitet u liječenju oligometastatske bolesti. U ovom radu će biti govora i o protonskoj terapiji 
i njenim jedinstvenim fizikalnim svojstvima.
KLJUČNE RIJEČI:  radioterapija snopovima promjenjivog intenziteta, volumetrijski modulirana lučna terapija, slikom vođena 
radioterapija, adaptivna radioterapija, stereotaktička ablativna radioterapija, terapija protonima
INTRODUCTION
Radiotherapy is one of the cornerstones for 
treating oncological patients along with surgery 
and different systemic therapies; approximately 
50% of cancer patients will require a radiothera-
peutic treatment at some point (1). Depending on 
the cancer type, and stage of the disease, four 
types of radiotherapy can be discerned: curative, 
neoadjuvant, adjuvant and palliative. Radiothera-
py can be performed as a single modality treat-
ment, or it can be combined with other treatment 
modalities sach as chemotherapy, immunothera-
py, hormonal therapy or surgery. The main mech-
anism of radiotherapy is to produce irreversible 
damages to the DNA molecule in malignant cells, 
by application of ionizing radiation. Radiotherapy 
is not only used in treating malignant diseases, 
but also in treating benign diseases such as: keloid 
scars, trigeminal neuralgia, acoustic schwannoma, 
pterygium, heterotopic ossification and arteriove-
nous malformation in the brain. In its beginnings, 
older radiotherapy techniques were less accurate 
and provided limited data on actual radiation 
dosage to the target volume and organs at risk. 
Rapid technological advances that occurred in the 
last thirty years enabled swift advancement of the 
procedure, as radiotherapy progressed from two-
dimensional conventional radiotherapy to three-
dimensional conformal radiotherapy (3D CRT). 
By using special CT/MR device and software, ra-
diation oncologist can plan the radiotherapy and 
contour the tumour’s volume and organs at risk, 
as well as provide precise information about de-
livered radiation dose. In conformal radiotherapy 
the radiation beam is shaped according to the con-
tour of the target volume. With this technique 
overall radiation dose can be increased and 
healthy tissues remain spared with fewer side ef-
fects of the treatment. Further progress in technol-
ogy represent more conformal and sophisticated 
radiotherapy techniques, known as: intensity-
modulated radiation therapy (IMRT), volumetric 
modulated arc therapy (VMAT), stereotactic abla-
tive radiotherapy (SABR), image guided radiation 
therapy (IGRT), proton therapy and adaptive ra-
diotherapy.
Intensity Modulated Radiation Therapy (IMRT)
One of the more advanced forms of three-di-
mensional conformal radiotherapy is IMRT. The 
IMRT technology has been developed in the 1990s, 
and by the late 1990s it was commercially avail-
able in only the most advanced oncology centres. 
Development of this technology was enabled by 
sophisticated computers that control a linear ac-
celerator and motorised multileaf collimators. In 
comparison with conformal 3D radiotherapy, 
IMRT has two key additional features: it uses 
beams that have changing dose intensity accross 
them during the radiotherapy and enables perfor-
mance of computerised inverse planning. Modu-
lation of beams is achieved by movement of mul-
tileaf collimators during the radiation process. 
The aim of this process is to bulid up the desired 
dose distribution. The modulation of the beams is 
achieved by generating beamlets of different sizes, 
which are shaped by the reposition of multileaf 
collimators. Result of using numerous modulated 
beams on the target volume is a delivery of highly 
conformal dose to the target volumes, and simul-
taneously maximal protection of nearby healthy 
tissues from the irradiation damage. High preci-
sion and a high level of conformity enables escala-
tion of the dose and it additionally protects the 
healthy tissue. Two varieties of radiation tech-
niques are possible in IMRT. First technique is 
segmental MLC technique or step and shoot tech-
nique (2). In this technique, every beam is divided 
into several segments with different positions of 
the collimator leaves. Radiation occurs only when 
leaves reach a new position. By adding up all seg-
ments, field of modulated intensity is created. Sec-
ond technique is dynamic one, as radiation occurs 
continually, even during movement of collimator 
leaves. Modulation of the beam is achieved by 
variations in the speed and distance among the 
leaves (3).
Unlike classical forward planning, IMRT 
technology enables performance of computerised 
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inverse planning method. During the process of 
forward planning, the physicists choose the ener-
gy of the beams, their directions, sizes, wedges 
and other parameters in order to obtain optimal 
dose distribution. In IMRT, the possible positions 
of collimator leaves are so numerous, that it would 
be too difficult for a physicist to choose the opti-
mal combinations of beams and size of the seg-
ments. In inverse planning the computer system is 
provided by the informations about needed dose 
and its desired distribution on a target volume 
and about the dose limitations to the organs at 
risk. During the optimization process, the com-
puter is trying to stay within given limitations and 
apply the calculated dose to the target volume by 
adjusting size and weight of every individual 
beam. It is important that the treatment planning 
system is supplied with complex and best possible 
parameters in order to produce the most optimal 
radiotherapy plan. After the optimization process 
and needed modulations, it is a clinical decision 
which plan is acceptable.
A study which compared forward and inverse 
planning in head and neck cancers has shown that 
inverse planning gives better results in covering 
target volume and a lesser dose on OAR. When 
compared to forward planning, inverse planning of 
radiotherapy in several cases of head and neck can-
cers enabled better protection of parotid glands (4).
By IMRT technique it is possible to simulta-
neously irradiate several target volumes, e.g. mul-
tiple brain metastasis (healthy brain tissue is 
spared). Different target volumes can simultane-
ously be treated by different fraction sizes and 
overall doses. For example, primary target vol-
ume (e.g. oropharyngeal cancer and pathological 
lymph node in the neck) can be irradiated to the 
overall dose, up to 60 Gy within 25 fractions, 2.4 
Gy applied per fraction, while simultaneously 
covering secondary target volume (lymph nodes 
under risk), up to dose of 50 Gy within 25 frac-
tions, 2 Gy applied per fraction (5). Better cover-
age of target volume and better conservation of 
organs at risks enables reirradiation by using 
IMRT technique. IMRT is especially valuable in 
treating head and neck cancers, due to proximity 
of numerous radiosensitive tissues/organs. IMRT 
reduces acute and late side effects of radiation 
when compared to classic 3D CRT. It has been 
shown that that IMRT can severely reduce the 
acute and late xerostomia (6). Nowadays, IMRT is 
used often in treating head and neck cancer, CNS 
tumours, prostate cancer, gynaecological tumours, 
esophageal and breast cancer. To summarize, ad-
vantages of IMRT are as following: greater accu-
racy in distribution and homogeneity of the dose, 
better protection of the critical organs, ability to 
give inhomogeneous dose throughout the various 
regions of the body, the possibility of dose escala-
tion, higher conformity of radiotherapy (7). Possi-
ble downside of IMRT is higher cost; more expen-
sive linear accelerator, sophisticated software, 
computer systems and networks, dosimetry, nec-
essary investments in additional quality assur-
ance and greater number of staff. Moreover, dur-
ing the IMRT, the integrating dose of radiation is 
generally higher, which can result in greater pos-
sible risk of secondary malignancies (increased 
monitor units) (12). IMRT requires great precision 
in contouring of target volumes and the organs at 
risk, as well as more intensive quality assurance 
process (7,8). However, although IMRT technique 
is complex and demanding, its advantages are sig-
nificant and this method is higly recomended in 
the teatment of numerous malignant diseases (8).
Volumetric Modulated Arc Therapy (VMAT)
Radiotherapy was affected by technological 
advances in the last several decades, new imaging 
techniques and treatment planning systems were 
introduced and linear accelerators were devel-
oped. This development was initially started by a 
need for higher radiation dose on target volume 
and at the same time conservation of the organs at 
risk, which resulted in better tolerance of the ra-
diation treatment with lower rate of acute and late 
side effects. High conformity, distribution of inho-
mogeneous dose and dose escalation is enabled 
by IMRT technique. Futher technology advance-
ment represents the development of rotation-
based technologies like VMAT and tomotherapy. 
VMAT was developed in 2007 and just like the 
IMRT, it enables very high distribution of the con-
formal dose; however, unlike the IMRT, it has 
three additional parameters, which can be modi-
fied during the radiation process. During the ra-
diation process gantry rotates of up to 360 degrees 
and has the ability to modify the rotation’s speed. 
It simultaneously enables variation of collimators’ 
leaf translation and the dose rate (9). This enables 
VMAT to have several more beam entry angles, 
which consequently reduces the duration of the 
radiation and fewer number of monitor units, in 
comparison with the IMRT (10). According to Ber-
Lib Oncol. 2019;47(2-3):91–97
94
telsen’s study, where IMRT and single arc VMAT’s 
plans for treatment of oropharyngeal and hypo-
pharyngeal cancer were compared, the results 
showed equal or better coverage of target volume, 
with better protection of OAR while using VMAT 
algorithm. VMAT technique was associated with 
reduced number of monitor units by 8.5% per 
fraction and 35% of reduction in treatment dura-
tion (11). Similar results were shown by numerous 
other studies with different malignant deseases, 
e.g. cervical cancer, prostate cancer and brain tu-
mours. VMAT resulted in better protection of 
OAR. Additionally, significant and constant dif-
ference between IMRT and VMAT is the reduced 
number of monitor units and a shorter treatment 
duration time in VMAT. Some studies have shown 
some equivalent results in comparison between 
IMRT and VMAT. Studies that compared VMAT 
and 3D CRT technique, have shown that VMAT 
has the superiority in administration of homoge-
neous dose and OAR protection (10). In both tech-
niques, VMAT and IMRT, have been reported an 
increase in low dose radiation to surrounding 
healthy tissue. This increases the risk of secondary 
tumours and it is estimated that the incidence of 
secondary tumour could increased from 1 to 1.75% 
on patients who live on for 10 years (12).
Image Guided Radiotherapy (IGRT)
From it’s very beginning, radiotherapy relied 
on radiological imaging techniques. Due to the 
technological advances and development of 3DCRT 
and IMRT, it became particularly important to dis-
play target volume during the radiation as accurate 
as possible. By doing so, one ensures that higher 
dose can be applied to the target volume with the 
protection of the healthy tissues. Nowadays, differ-
ent diagnostic imaging can be used, such as: UZV, 
CT, MRI and PET/CT. Recent technological ad-
vancements enabled integration of some of those 
diagnostic imaging with the linear accelerator. Tra-
ditionally, portal imaging is used for the control of 
patients’ position during the radiation process. 
Later on, Electronic Portal Imaging Device or EPID 
came into use, which is attached to linear accelera-
tor and provides a digital image of better quality 
and contrast in comparison with portal imaging. 
EPID produces images of high quality when de-
picting bone structures; however, it produces poor 
images of soft tissues. Due to that fact, it is consid-
ered unessential if the tumour is not near or not in 
the bones; however, it still gives valuable informa-
tion about the patient’s position.
New technologies such as cone-beam CT 
provide a better contrast of soft tissues. During the 
radiation process, which usually takes up for 
weeks, there is a possibility of great variation in 
the position of patient and in possible size and lo-
cation of target volumes, between fractions and 
even during the fraction itself. The most impor-
tant factor is a precise positioning of the patient, in 
order to achieve accuracy and reproducibility. For 
thit purpose, skin markers, immobilization masks 
and pillows, fixators and vacuum mattresses can 
be used. Despite these aids, variations among frac-
tions can still be significant. The treatment posi-
tion of the patient should be regulary checked and 
if necessary, the reposition before the treatment 
should be done (13). Those variations in treatment 
volumes positions can be more significant by cer-
tain tumors, such as lung cancer or by abdominal 
tumors. In order to achieve escalation of treatment 
dose and reducing the dose on OAR, IGRT can en-
able todetect and remove these variations. This is 
a necessary process in modern highly accurate ra-
diation techniques such as IMRT (14). IGRT is im-
portant because it detects movements of organs 
between the fractions. It has been shown that 
esophagus, for example, can drastically change its 
position in a lateral direction due to the peristalsis 
(15). The position of prostate can be also changed 
during the radiotherapy treatment. This organ 
movements can be influenced by different factors, 
such as the fullness ofrectum (14).The radiation of 
paraaorthic lymph nodes requires attention on 
possible movements of the kidneys (14).
During the radiotherapy of head and neck 
cancers, patients can have side effects such as: mu-
cositis, nausea and vomiting, which can result in a 
drastic loss of body mass, which in turn results in 
anatomical differences that are seen on cone beam 
CT. All structures are then moved towards the 
centre so as a result skin and parotids are more 
exposed to radiation (16). During the radiothera-
py of radiosensitive tumours, e.g. lymphomas, it 
is possible that tumour drastically losses volume 
and consequently radiosensitive organs in prox-
imity of target volume could receive higher radia-
tion dosage. Imaging during the radiation therapy 
can discover a progression of the cancerous mass, 
and by doing so spare the patient of undergoing 
unnecessary radiation. It is possible that intrafrac-
tional variations such as patient moving and mo-
95
Lib Oncol. 2019;47(2-3):91–97
bility of internal organs such as lungs, kidneys 
and stomach take place alongside with interfrac-
tional variations. During the breathing, lung tu-
mour can move up to 3 cm, which necessitates a 
greater margin and additionally irradiates a huge 
portion of healthy tissues, which decreases the 
treatment’s accuracy. To solve this problem, tech-
nique known as respiratory gating had been de-
veloped. In this technique, the tumour is treated 
only in a particular position whilst breathing (17). 
Another technique of irradiating mobile tumours 
is known as the tracking method, where irradiat-
ing beam follows the tumour. Both techniques are 
demanding and relatively expensive. However, 
IGRT is an irreplaceable technique in modern ra-
diooncology and is used in IMRT, VMAT, SABR 
and particle therapy. It is important to note that 
not every patient is suitable for IGRT. It is indi-
cated for the tumours that are positioned near the 
radiosensitive organs, where steep decrease of 
dose is required, abdominal and pelvical tumours 
where filling of organs (e.g. bladder, rectum) re-
sults in changes of anatomy, or in cases where 
dose escalation is needed. IGRT must be used ra-
tionally, because by using it exposes patient to ex-
tra radiation which amounts to between 0.1 and 
3% of the treatment dose (18).
Adaptive Radiotherapy
Adaptive radiotherapy is an extension of 
IGRT. It’s purpose is to modify and adjust the ra-
diation plan during the treatment because of inevi-
table changes in anatomy caused by tumor shrink-
age, changes in tumour biology, movement of ad-
jacent organs, addition of chemotherapeutics or 
patients’ weight loss. Replanning during the treat-
ment is often demanding, especially by techniques 
such as VMAT and IMRT. This problem can be 
countered by taking potential changes in patients’ 
anatomy into consideration before the therapy 
starts and make multiple treatment plans. Before 
the radiation process and on the daily basis, pa-
tients’ anatomy is inspected by imaging methods 
and according to the patient anatomy, an optimal 
plan is chosen. During radiation of head and neck 
carcinomas as an example, parotid glands often 
move medially 4.2 millimetres towards the greater 
dose by average. Takings this into consideration, it 
is wise to replan patients (19).
It is well known in oncology that cancerous 
tissues are heterogeneous, formed from various 
clones that are a result from instability of tumour’s 
genome. Heterogeneity of the tumour is an impor-
tant factor in cancer re-emergence and progression. 
Various clones are differently sensitive to the radia-
tion, therefore, inhomogeneous distribution of the 
dose on the cancerous tissue would be desirable. 
Using that as a premise, a new approach to radio-
therapy has been formed, which integrates molecu-
lar and functional imaging with anatomical infor-
mation. Two main strategies in achieving dose 
paintings are: dose painting by contours and dose 
painting by numbers. In former approach, within 
the target volume, areas of greater risk receive an 
extra boost. In the later approach, the dose is deter-
mined on the voxel level, therefore every individu-
al voxel receives an individualized dose. Main fo-
cus of the dose painting procedure is on three prov-
en causes of radiotherapeutic failures: tumour 
burden, hypoxia and tumour cell proliferation (20).
Proton Therapy
Radiotherapy with heavy particles, such as 
protons, neutrons and carbon ion is a very prom-
ising approach in therapy of malignant deseases. 
Most commonly used therapy with particles is the 
proton therapy, which is conducted in over 75 
specialised centers across the world (21). The main 
advantages of the proton beams derive from their 
physical characteristics, where the proton of se-
lected energy does not traverse the entire target, 
but stops at an exactly set depth. The maximum 
dose is applied just before the particle stops, which 
is known as Bragg’s peak. According to it, steep 
fall of the dose to the 0 value can be seen. Proton 
beam does not have an exit dose and due to that 
fact, it completely conserves the healthy tissues 
distal to the target. Additionally, it has minimal 
lateral scattered dose (22). Current evidence sug-
gests that there is a smaller number of acute and 
late side effects when using proton therapy in 
comparison to photon therapy (23). Proton thera-
py enables escalation of the dose, optimal preser-
vation of healthy tissues and in extent, treatment 
of radioresistant tumours, such as: sarcomas, 
chondrosarcoma, uveal melanoma, skull base tu-
mours, paraspinal tumours, paediatric tumours 
and reirradiation (24).
Stereotactic Body Radiotherapy (SBRT)
Stereotactic body radiotherapy (SBRT) or ste-
reotactic ablative radiotherapy (SABR) is a new, 
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non-invasive treatment, created by following the 
model of stereotactic radiosurgery (SRS) by gam-
ma knife in treating brain metastases. Terms like 
SBRT and SARB are used to describe treatments of 
tumours outside the central nervous system, while 
the term SRS is used to describe the treatment of 
lesions within the central nervous system. SABR is 
based on highly conformal, high dose and precise 
beams, for the treatment of small tumours under 
imaging control. Unlike the classical fractional ra-
diotherapy (3DCRT, IMRT, VMAT, IGRT), SABR 
enables hypofractionation, i.e. distribution of 
higher radiation dose within one or several frac-
tions. This results in the reduction of therapy’s du-
ration from several weeks to few days (25). Devel-
opment of today’s SABR technique is enabled by 
modern linear accelerators, advanced imaging 
modality during the radiation, reproducible im-
mobilizing systems and by using IMRT/VMAT 
planning techniques. All of the factors enabled the 
delivery of highly precise radioablative dose on 
the tumour, while sparing healthy tissues. If SABR 
technique is conducted precisely, side effects of 
grade 3 or higher are rare. It has been shown that 
they can occur in 15% of patients with lung cancer 
and 18% of patients with liver metastasis (26). Due 
to high dose within a fraction, possibility of rare 
and serious side effects has been described: fatal 
haemoptysis, bone fractures, myelopathy, plexop-
athy and chronic pain. SABR enabled the treat-
ment of oligometastatic disease in extra and intra-
cranial sites. Numerous non-randomised studies 
have shown that control rate of treated metastasis 
is 80% and 2-5 year progression free survival of 
20%. SABR helps with postponing the progression 
and continuation of chemotherapy and also in-
creases the quality of life (27). By using SABR 
technique, primary irradiation of low risk and in-
termediate risk prostate carcinomas has proven to 
be a successful, effective and safe method, as only 
3% of treatment (among 500 patients) was unsuc-
cessful (28). Studies have shown that patients with 
early stage, non-small cell lung cancer can be 
treated with SABR as an alternative to a radical 
surgical procedure. 70% of patients who were 
treated by SARB and 68% of patients who have 
undergone surgery survived for 2 years (29).
CONCLUSION
Radiotherapy is a branch of medicine that re-
lies not only on medical knowledge, but also on 
knowledge in fields of chemistry, physics and biol-
ogy. New techniques of radiotherapy have made 
great progress in local control of malignant deseas-
es, in patient’s survival, quality of life and treat-
ment toxicity reduction. The outcome of malignant 
disease depends on many factors such as histo-
pathological properties of the tumor, type and ef-
ficacy of the therapy, possible side effects etc. Con-
sidering all the above and the wide variety of dif-
ferent radiotherapy techniques and their specific 
physical and radiobiological properties, an indi-
vidualized approach to each patient is important. 
In the future, we expect even more personalized 
approach based on the results of numerous inves-
tigations in the fields of tumour biology, biomark-
ers, tumour microenvironment, immunotherapy, 
combinations of therapies and further develop-
ment in diagnostic and imaging technologies, bio-
informatics and predictive models (30-32).
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